subject: PR:000010424

object_name: Erectile Dysfunction, CTCAE


subject: PR:000010424

subject_name: homeobox protein MIXL1

object_name: Erectile dysfunction

tested_intervention: unsure


subject: PR:000010424

object_name: Adult Penile Carcinoma


subject: PR:000010424

object_name: penis carcinoma


subject: PR:000010424

object_name: penile cancer


subject: PUBCHEM.COMPOUND:124223334

subject_name: Oratopo

object_name: Childhood Solid Neoplasm

tested_intervention: yes


subject: PUBCHEM.COMPOUND:124223334

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:124223334

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: Childhood Gastric Carcinoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: cholestasis


subject: PUBCHEM.COMPOUND:4689

subject_name: Paromomycin I

object_name: cryptosporidiosis


subject: PUBCHEM.COMPOUND:4689

object_name: HIV infection


subject: CHEBI:7934

subject_name: Paromomycin


subject: CHEBI:7934


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Inflammatory Response


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:31859

subject_name: Modafinil

object_name: Delayed Emergence from Anesthesia


subject: CHEBI:91899

object_name: outcomes general quality of life


subject: CHEBI:91899

object_name: Perceived quality of life


subject: CHEBI:91899

object_name: Good quality of life


subject: CHEBI:91899

object_name: Hypoventilation


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: cutaneous lupus erythematosus


subject: CHEBI:58097

object_name: Congenital postural scoliosis


subject: CHEBI:58097

object_name: scoliosis


subject: CHEBI:58097

object_name: Scoliosis, CTCAE


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: DRUGBANK:DB16497


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Parkinson disease


subject: UMLS:C3658787

object_name: Stomach cancer


subject: UMLS:C3658787

object_name: gastric cancer


subject: UMLS:C3658787

object_name: small cell lung carcinoma


subject: UMLS:C3658787

object_name: cervical cancer


subject: UMLS:C3658787

object_name: cervical carcinoma


subject: UMLS:C3658787

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3658787

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3658787

object_name: clear cell renal carcinoma


subject: UMLS:C3658787

object_name: renal cell adenocarcinoma


subject: UMLS:C3658787

object_name: renal cell carcinoma


subject: UMLS:C3658787

object_name: trabecular adenocarcinoma


subject: UMLS:C3658787

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C3658787

object_name: Microsatellite Instability


subject: UMLS:C3658787

object_name: liver carcinoma


subject: UMLS:C3658787

object_name: mismatch repair cancer syndrome 1


subject: UMLS:C3658787

object_name: Turcot syndrome


subject: UMLS:C3658787

object_name: Mismatch Repair Deficiency


subject: UMLS:C3658787

object_name: urothelial carcinoma


subject: UMLS:C3658787

object_name: transitional cell carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Stomach cancer


subject: UNII:KXG2PJ551I

object_name: gastric cancer


subject: UNII:KXG2PJ551I

object_name: small cell lung carcinoma


subject: UNII:KXG2PJ551I

object_name: cervical cancer


subject: UNII:KXG2PJ551I

object_name: cervical carcinoma


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:4672

subject_name: Docetaxel

object_name: colorectal cancer


subject: CHEBI:4672

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:49956

subject_name: Xenon

object_name: bipolar disorder


subject: CHEBI:49956

object_name: bipolar depression


subject: CHEBI:49956

object_name: endogenous depression


subject: CHEBI:49956

object_name: major depressive disorder


subject: UMLS:C1827106

subject_name: Dipeptidyl-Peptidase IV Inhibitors

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Effects of immunotherapy


subject: CHEBI:231679

object_name: Adverse effect of radiation therapy


subject: CHEBI:231679

object_name: Disorder due to radiotherapy


subject: UMLS:C0939333

subject_name: Estradiol Patch

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: chronic pain (diagnosis)


subject: PUBCHEM.COMPOUND:521372

object_name: Chronic pain


subject: CHEBI:31355

subject_name: Carboplatin

object_name: female reproductive organ cancer


subject: CHEBI:31355

object_name: High grade serous carcinoma


subject: UMLS:C4724142

subject_name: Amorphous Calcium Carbonate

object_name: calcium measurement


subject: UMLS:C4724142

object_name: Bone Mineral Density


subject: UMLS:C4724142

object_name: osteoporosis


subject: UMLS:C4724142

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C4724142

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C4724142

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: cancer


subject: CHEBI:93363

subject_name: Naphazoline


subject: CHEBI:69477

subject_name: Cannabigerol

object_name: rheumatoid arthritis


subject: CHEBI:69477

object_name: inflammatory disease


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal


subject: PUBCHEM.COMPOUND:89465


subject: UMLS:C1452313

subject_name: CBG brand of calcium gluconate


subject: UMLS:C1452313


subject: PR:000007869

subject_name: cytosolic beta-glucosidase


subject: PR:000007869


subject: PR:000014686

subject_name: corticosteroid-binding globulin


subject: PR:000014686


subject: UMLS:C0040643

subject_name: Transcortin


subject: UMLS:C0040643


subject: CHEBI:44915

subject_name: Propofol

object_name: erection; incomplete


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UMLS:C2976294

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C2976294

object_name: pulmonary hypertension


subject: UMLS:C2976294

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C2976294

object_name: pulmonary arterial hypertension


subject: CHEBI:7852

subject_name: Oxycodone

object_name: cesarean section; complications


subject: CHEBI:28747

subject_name: Picolinic acid

object_name: HIV infection


subject: CHEBI:50369

subject_name: Chromium picolinate


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: DS Stage II Plasma Cell Myeloma


subject: UNII:15C2VL427D

object_name: ISS Stage II Plasma Cell Myeloma


subject: UNII:15C2VL427D

object_name: ISS Stage III Plasma Cell Myeloma


subject: UNII:15C2VL427D

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C5555065

subject_name: KAT6 Inhibitor PF-07248144

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555065

object_name: breast carcinoma


subject: UMLS:C5555065

object_name: breast cancer


subject: UMLS:C3827066

subject_name: DS-3032 Tosylate

object_name: plasma cell myeloma


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: UMLS:C2604519

object_name: maturity-onset diabetes of the young type 1


subject: MESH:C520497

subject_name: MoviPrep

object_name: Obscure gastrointestinal hemorrhage


subject: CHEBI:66964

subject_name: Dronabinol

object_name: sickle cell disease


subject: CHEBI:167997

subject_name: Cellulose, microcrystalline


subject: CHEBI:62968

subject_name: Microcrystalline cellulose


subject: CHEBI:49960

subject_name: Vandetanib

object_name: precancerous condition


subject: CHEBI:49960

object_name: lip and oral cavity squamous cell carcinoma


subject: CHEBI:49960

object_name: verrucous carcinoma of oral cavity


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Fasting


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Shock


subject: CHEBI:17061

object_name: Critical Illness


subject: CHEBI:17061

object_name: Physical trauma


subject: CHEBI:17061

object_name: Injury


subject: CHEBI:17061

object_name: Trauma


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: heart failure


subject: UMLS:C0384570

object_name: Heart Failure, CTCAE


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Mental deterioration


subject: UNII:71M78END5S

object_name: Cognitive impairment


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: UMLS:C5203254

subject_name: Rituximab Liquid Injection

object_name: Acute lymphoblastic leukemia, in relapse


subject: UMLS:C5203254

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:U2H19X4WBV

subject_name: Tomivosertib

object_name: acute myeloid leukemia by FAB classification


subject: UNII:U2H19X4WBV

object_name: acute myeloid leukemia


subject: UMLS:C0699925

subject_name: Rimactane

object_name: tuberculosis


subject: CHEBI:6801

subject_name: Metformin

object_name: Leukokeratosis


subject: CHEBI:6801

object_name: hyperplasia


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785

object_name: esophageal adenocarcinoma


subject: CHEBI:114785

object_name: esophageal squamous cell carcinoma


subject: CHEBI:114785

object_name: gastric adenocarcinoma


subject: CHEBI:114785

object_name: Malignant neoplasm of stomach stage II


subject: CHEBI:114785

object_name: Malignant neoplasm of stomach stage III


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage II Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage II Esophageal Cancer


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Stage III Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage III Esophageal Cancer


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: suppressor of tumorigenicity 3


subject: GTOPDB:12349

subject_name: zimberelimab


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C3152525

subject_name: Buffered Lidocaine

object_name: female reproductive system disorder


subject: CHEBI:64317

subject_name: Isoprenaline

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:64317

object_name: obesity


subject: CHEBI:64317

object_name: Obesity, CTCAE


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Metastatic Cervical Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: Seizure Related to COVID-19


subject: CHEBI:3387

object_name: visual epilepsy


subject: CHEBI:60654

subject_name: valproate


subject: CHEBI:60654


subject: CHEMBL.COMPOUND:CHEMBL5314892

subject_name: VEVOCTADEKIN

object_name: Plasma cell myeloma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314892

object_name: Plasma cell myeloma recurrent


subject: UMLS:C5557203

subject_name: Vevoctadekin


subject: UMLS:C5557203


subject: UMLS:C5943209

subject_name: Affitope AD01

object_name: Alzheimer disease


subject: CHEBI:95165

object_name: colorectal carcinoma


subject: CHEBI:95165

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Inflammation


subject: MESH:D002136

object_name: hyperlipidemia


subject: MESH:D002136

object_name: hyperlipoproteinemia


subject: MESH:D002136

object_name: Hyperlipidemia, CTCAE


subject: MESH:D002136

object_name: Serum lipids high (finding)


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine


subject: UMLS:C0728976


subject: UMLS:C0728976


subject: UMLS:C0728976


subject: UMLS:C0728976


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UMLS:C1446647

subject_name: Milk antigen


subject: UMLS:C1446647


subject: UMLS:C1446647


subject: UMLS:C1446647


subject: UMLS:C1446647


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: CHEBI:36080

subject_name: protein


subject: CHEBI:36080


subject: CHEBI:36080


subject: CHEBI:36080


subject: CHEBI:36080


subject: UMLS:C0033684

subject_name: Proteins


subject: UMLS:C0033684


subject: UMLS:C0033684


subject: UMLS:C0033684


subject: UMLS:C0033684


subject: PR:000000001


subject: PR:000000001


subject: PR:000000001


subject: PR:000000001


subject: PR:000000001


subject: CHEBI:63631

subject_name: Topiramate

object_name: Compulsive shopping


subject: UMLS:C5203993

subject_name: Antifungal PC945

object_name: lung transplant infection


subject: UMLS:C5203993

object_name: aspergillosis


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: neoplastic meningitis


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: GTOPDB:10492

subject_name: envafolimab


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: CHEBI:10033

subject_name: Warfarin

object_name: Huntington disease


subject: CHEBI:10033


subject: UNII:H52ITZ9X9D

subject_name: ACASUNLIMAB

object_name: Solid Neoplasm


subject: UNII:H52ITZ9X9D

object_name: cervical cancer


subject: UNII:H52ITZ9X9D

object_name: cervical carcinoma


subject: UNII:H52ITZ9X9D

object_name: triple-negative breast carcinoma


subject: UNII:H52ITZ9X9D

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:H52ITZ9X9D

object_name: head and neck squamous cell carcinoma


subject: UNII:H52ITZ9X9D

object_name: non-small cell lung carcinoma


subject: UNII:H52ITZ9X9D

object_name: endometrial carcinoma


subject: UNII:H52ITZ9X9D

object_name: urothelial carcinoma


subject: UNII:H52ITZ9X9D

object_name: transitional cell carcinoma


subject: UMLS:C5417901

subject_name: BNT 311


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C5417901


subject: UMLS:C2349988

subject_name: Myobacterium w (attenuated)

object_name: castration-resistant prostate carcinoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: habitual spontaneous abortion


subject: CHEBI:27470

object_name: pregnancy loss, recurrent, susceptibility to, 1


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: CHEBI:192614

subject_name: Homosildenafil


subject: CHEBI:192614


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: UMLS:C5227659

object_name: Diabetes


subject: UMLS:C5227659

object_name: diabetes mellitus


subject: UMLS:C5227659

object_name: Organizing inflammation


subject: UMLS:C3852499

object_name: Hepatic impairment


subject: UMLS:C3852499


subject: UMLS:C3852499

object_name: liver cirrhosis


subject: GTOPDB:10659

subject_name: bempegaldesleukin

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL4298058

subject_name: BEMPEGALDESLEUKIN


subject: UMLS:C4309517


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: systemic inflammatory response syndrome


subject: CHEBI:100241

object_name: Postoperative shock


subject: CHEBI:100241

object_name: Complication of extracorporeal circulation


subject: CHEBI:100241

object_name: coronary artery disorder


subject: CHEBI:100241

object_name: coronary atherosclerosis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: HIV infection


subject: UMLS:C2698151


subject: CHEBI:4672

subject_name: Docetaxel

object_name: male reproductive organ cancer


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108102


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Neck Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: head and neck neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: head and neck cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: AIDS


subject: GTOPDB:13658

subject_name: olezarsen

object_name: atherosclerosis


subject: GTOPDB:13658

object_name: hypertriglyceridemia


subject: GTOPDB:13658

object_name: Hypertriglyceridemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4650438

subject_name: OLEZARSEN


subject: CHEMBL.COMPOUND:CHEMBL4650438


subject: CHEMBL.COMPOUND:CHEMBL4650438


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Diabetic


subject: UMLS:C1541530

object_name: metastatic colorectal cancer


subject: CHEBI:135207

subject_name: Clofedanol

object_name: systemic sclerosis


subject: CHEBI:15365

subject_name: Aspirin


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Non-small cell carcinoma


subject: UMLS:C0013227

object_name: lung adenocarcinoma


subject: UMLS:C0013227

object_name: large cell carcinoma


subject: UMLS:C0013227

object_name: squamous cell carcinoma


subject: UMLS:C0013227

object_name: lung neoplasm


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: hepatitis C


subject: UNII:8ZHS5657EH

subject_name: Tagraxofusp

object_name: Myelodysplasia


subject: UNII:8ZHS5657EH

object_name: Adult Myelodysplastic Syndrome


subject: UNII:8ZHS5657EH

object_name: childhood myelodysplastic syndrome


subject: UNII:8ZHS5657EH

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Recurrent ovarian cancer


subject: CHEBI:41879

object_name: ovarian serous tumor


subject: CHEBI:41879

object_name: ovarian clear cell tumor


subject: CHEBI:41879

object_name: borderline epithelial tumor of ovary


subject: CHEBI:41879

object_name: ovarian endometrial cancer


subject: CHEBI:41879

object_name: Adnexal mass


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243

object_name: ovarian cancer


subject: CHEBI:168243

object_name: ovarian neoplasm


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: UMLS:C5780612

subject_name: High Caffeine

object_name: Caffeine-related disorder


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Gastrointestinal symptom


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C5446554

object_name: squamous cell carcinoma


subject: UMLS:C5446554

object_name: malignant soft tissue neoplasm


subject: UMLS:C5446554

object_name: sarcoma


subject: UMLS:C5446554

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5433059

subject_name: seal oil

object_name: Polyarthritis


subject: MESH:D014131

subject_name: Trace Elements

object_name: pervasive developmental disorder


subject: MESH:D014131

object_name: autism


subject: MESH:D014131

object_name: autism spectrum disorder


subject: UMLS:C0282575

subject_name: Micronutrients


subject: UMLS:C0282575


subject: UMLS:C0282575


subject: UMLS:C3489751

object_name: cardiovascular disorder


subject: UNII:4N9P6CC1DX

subject_name: Echinacea

object_name: Upper Respiratory Infections


subject: UNII:4N9P6CC1DX

object_name: respiratory tract infectious disorder


subject: UNII:4N9P6CC1DX

object_name: Recurrent upper respiratory tract infections


subject: UMLS:C5445960

subject_name: Echinacea antigen


subject: UMLS:C5445960


subject: UMLS:C5445960


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals

object_name: optic neuritis


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C5222498

subject_name: Secukinumab Liquid Injection

object_name: Chronic small plaque psoriasis


subject: CHEBI:52763

object_name: HIV-1 infection


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: Shift-work related sleep disturbance


subject: CHEBI:149504

object_name: tetralogy of fallot


subject: CHEBI:149504

object_name: Right Ventricular Dysfunction


subject: CHEBI:149504

object_name: congenital heart disease


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: GTOPDB:12989

subject_name: toripalimab

object_name: oral cavity squamous cell carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: EXCESS LMW-DNA


subject: UMLS:C5417947


subject: UMLS:C5702559

subject_name: Lactase Enzyme (brand name)

object_name: Acquired lactase deficiency


subject: UMLS:C0083183

subject_name: lactase


subject: CHEBI:233644

subject_name: Senicapoc

object_name: asthma


subject: CHEBI:233644

object_name: Exercise-induced asthma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: peripheral vascular disease


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: eosinophilic gastroenteritis


subject: UMLS:C3658854


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: body weight


subject: CHEBI:231594

subject_name: Norgestrel


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: end stage renal failure


subject: UMLS:C0770246

object_name: Chronic uremia


subject: CHEBI:6931

subject_name: Midazolam

object_name: hepatitis


subject: CHEBI:6931

object_name: Chronic hepatitis


subject: CHEBI:6754

subject_name: Meperidine


subject: CHEBI:6754


subject: CHEBI:6754

object_name: Cirrhosis


subject: CHEBI:6754

object_name: liver cirrhosis


subject: CHEBI:6754

object_name: anxiety


subject: CHEBI:6754

object_name: anxiety disorder


subject: CHEBI:6754

object_name: Anxiety symptoms


subject: CHEBI:6754

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:6754

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:85078

object_name: Hepatic steato-fibrosis


subject: CHEBI:31401

subject_name: Cilostazol

object_name: arteriosclerosis disorder


subject: CHEBI:31401

object_name: atherosclerosis


subject: CHEBI:17458

subject_name: N-methyltyramine

object_name: staphylococcus aureus infection


subject: CHEBI:17458

object_name: Neonatal infection


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Bilateral tonic-clonic seizure


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Physical function


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: psoriasis


subject: PUBCHEM.COMPOUND:9920327

subject_name: ABAMECTIN

object_name: malaria


subject: CHEBI:39214

subject_name: abamectin


subject: CHEBI:5011

subject_name: Fenpyroximate


subject: GTOPDB:13049

object_name: Parkinson disease


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Tobacco user


subject: UMLS:C3854029

object_name: Tobacco use history


subject: UMLS:C3854029

object_name: Encounter due to tobacco use


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:17688

subject_name: Nicotine

object_name: alcohol consumption (history)


subject: PUBCHEM.COMPOUND:16119086

object_name: Alzheimer disease


subject: UNII:G3QE979K1X


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Embolic stroke of undetermined source


subject: PUBCHEM.COMPOUND:73151030

object_name: atrial fibrillation new onset


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Severe Extremity Pain


subject: CHEBI:7852

object_name: Neck Pain Score 6


subject: CHEBI:7852

object_name: Severe pain


subject: CHEBI:7459

subject_name: Naloxone


subject: CHEBI:7459


subject: CHEBI:7459


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: moyamoya disease 1


subject: PUBCHEM.COMPOUND:92043599

object_name: Moyamoya disease


subject: PUBCHEM.COMPOUND:92043599

object_name: Trephine hole


subject: PUBCHEM.COMPOUND:92043599

object_name: ischemic attack


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Pathologic vasoconstriction


subject: UMLS:C3714501

object_name: Vasoconstriction


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:84040

object_name: Androgen excess


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:6073

subject_name: Isradipine

object_name: nicotine dependence


subject: CHEBI:6073

object_name: Craving


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: Preterm Premature Rupture of Fetal Membranes


subject: CHEBI:2676

object_name: Premature rupture of membranes


subject: CHEBI:2676

object_name: premature birth (history)


subject: CHEBI:2676

object_name: pregnancy preterm


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: euthyroid Graves orbitopathy


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UNII:V038D626IF

subject_name: Ashwagandha


subject: CHEBI:141441

subject_name: Ile-Thr

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: coronary artery disorder


subject: CHEBI:7915

object_name: coronary atherosclerosis


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Cancer Other


subject: UMLS:C5222458

subject_name: Ketamine Hydrochloride Injection

object_name: bipolar disorder


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:231425

object_name: Acute heart failure


subject: PUBCHEM.COMPOUND:546807

subject_name: Pumice stone

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:546807

object_name: non-small cell lung carcinoma


subject: UMLS:C0719963

subject_name: Diprosone


subject: UMLS:C0719963


subject: CHEBI:8382

subject_name: Prednisone

object_name: Hyperglycemia steroid-induced


subject: UNII:Q8L6AN59YY

subject_name: Bitopertin

object_name: Compulsion


subject: UMLS:C1569697

object_name: melanoma


subject: UMLS:C1569697

object_name: metastatic melanoma


subject: UNII:6553U4VG91

object_name: mild neurocognitive disorder


subject: UNII:6553U4VG91

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:169450720

object_name: Cachexia


subject: UMLS:C5854592

subject_name: Anti-PD-1 Antibody AI-025/Anti-CTLA-4 Antibody ONC-392 Combination Formulation AI-061

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5854592

object_name: high grade ovarian serous adenocarcinoma


subject: UMLS:C5854592

object_name: Gastroesophageal junction cancer


subject: UMLS:C5854592

object_name: bile duct carcinoma


subject: UMLS:C5854592

object_name: bile duct cancer


subject: UMLS:C5854592

object_name: cholangiocarcinoma


subject: UMLS:C5854592


subject: UMLS:C5854592

object_name: primary peritoneal carcinoma


subject: UMLS:C5854592

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C5854592

object_name: peritoneal carcinoma


subject: UMLS:C5854592

object_name: liver carcinoma


subject: UMLS:C5854592

object_name: fallopian tube carcinoma


subject: UMLS:C5854592

object_name: fallopian tube cancer


subject: UMLS:C5854592

object_name: endometrial cancer


subject: UMLS:C5854592

object_name: uterine corpus cancer


subject: UMLS:C5854592

object_name: endometrial carcinoma


subject: UMLS:C5854592

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5854592

object_name: clear cell renal carcinoma


subject: UMLS:C5854592

object_name: renal cell adenocarcinoma


subject: UMLS:C5854592

object_name: renal cell carcinoma


subject: UMLS:C5854592

object_name: carcinoma of esophagus


subject: UMLS:C5854592

object_name: esophageal cancer


subject: UMLS:C5854592

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5854592

object_name: neoplasm of esophagus


subject: UMLS:C5854592

object_name: colorectal cancer


subject: UMLS:C5854592

object_name: colorectal carcinoma


subject: UMLS:C5854592

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854592

object_name: cervical cancer


subject: UMLS:C5854592

object_name: cervical carcinoma


subject: UMLS:C5854592

object_name: Stomach cancer


subject: UMLS:C5854592

object_name: gastric cancer


subject: UMLS:C5854592

object_name: bladder tumor


subject: UMLS:C5854592

object_name: urinary bladder carcinoma


subject: UMLS:C5854592

object_name: urinary bladder cancer


subject: UMLS:C5854592

object_name: childhood bladder carcinoma


subject: UMLS:C5854592

object_name: anus cancer


subject: UMLS:C5854592

object_name: anal carcinoma


subject: UMLS:C5854592

object_name: melanoma


subject: CHEBI:51799

subject_name: Imipenem


subject: CHEBI:51799

object_name: gram-negative bacterial infections


subject: CHEBI:51799

object_name: Antibiotic resistant infection


subject: CHEBI:51799

object_name: keratoconus posticus circumscriptus


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:190509


subject: PUBCHEM.COMPOUND:56971685

subject_name: Relebactam


subject: PUBCHEM.COMPOUND:56971685


subject: PUBCHEM.COMPOUND:56971685


subject: PUBCHEM.COMPOUND:56971685


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Disorder of shoulder


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:87631

subject_name: statin

object_name: Solid Neoplasm


subject: CHEBI:87631

object_name: ototoxicity


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:16414

subject_name: Valine

object_name: end stage renal failure


subject: CHEBI:16414

object_name: Chronic uremia


subject: CHEBI:9150

object_name: subarachnoid hemorrhage


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Mental health issue


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:29191

subject_name: hydroxyl


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: UMLS:C1134696


subject: CHEBI:64073

object_name: outcomes general quality of life


subject: CHEBI:64073

object_name: Perceived quality of life


subject: CHEBI:64073

object_name: Good quality of life


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: CHEBI:176724

subject_name: Etiracetam

object_name: amnesia


subject: CHEBI:176724

object_name: Memory Impairment, CTCAE 5.0


subject: CHEBI:176724

object_name: mild neurocognitive disorder


subject: CHEBI:176724

object_name: mild cognitive impairment


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: UMLS:C5666966

subject_name: Pegylated CD25/CD122-selective Interleukin-2 Mutein STK-012

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5666966

object_name: non-small cell lung carcinoma


subject: CHEBI:9241

subject_name: Spironolactone

object_name: End stage renal failure on dialysis


subject: CHEBI:6801

subject_name: Metformin

object_name: hepatobiliary disorder


subject: CHEBI:30021

subject_name: Selenomethionine


subject: CHEBI:30021

object_name: liver disorder


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:30314


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:62855

subject_name: beta-elemene


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Locally Advanced Renal Cell Carcinoma


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: MESH:C586932

subject_name: colloidal silver

object_name: Rhinosinusitis


subject: CHEBI:7575

subject_name: Nimodipine

object_name: Post-Operative Pain


subject: CHEBI:7575

object_name: Acute Pain


subject: UMLS:C3827109

subject_name: JAK Inhibitor INCB047986

object_name: Childhood Breast Carcinoma


subject: UMLS:C3827109

object_name: breast carcinoma


subject: UMLS:C3827109

object_name: breast cancer


subject: UMLS:C3827109

object_name: pancreatic neoplasm


subject: UMLS:C3827109

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3827109

object_name: malignant pancreatic neoplasm


subject: UMLS:C3827109

object_name: Childhood Solid Neoplasm


subject: UMLS:C3827109

object_name: Adult Solid Neoplasm


subject: UMLS:C3827109

object_name: Solid Neoplasm


subject: UMLS:C3827109

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C3827109

object_name: Embolism, Tumor


subject: UMLS:C3827109

object_name: Neoplasm Metastasis


subject: UMLS:C3827109

object_name: Advanced cancer


subject: UMLS:C3827109

object_name: Hodgkin Disease


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: sarcoidosis


subject: UNII:73SM5SF3OR

object_name: sarcoidosis, susceptibility to, 1


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Malignant neoplasm of pancreas resectable


subject: PUBCHEM.COMPOUND:14907381

object_name: Pancreatic cancer, adult


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410

object_name: Pancreatic cancer non-resectable


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UNII:P6YC3EG204

subject_name: Erythrotin

object_name: Pregnant


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:133021

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:133021

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:133021

object_name: anaplastic large cell lymphoma


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: malignant mesothelioma


subject: UMLS:C5427906

subject_name: atezolizumab + bevacizumab


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:231213

subject_name: Caffeinol

object_name: Acute Ischemic Stroke


subject: CHEBI:231213

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:74030550

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:74030550

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:74030550

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:74030550

object_name: malignant urinary system neoplasm


subject: UMLS:C1550146

subject_name: Other - Substance Type

object_name: space motion sickness


subject: CHEBI:8461

subject_name: Promethazine


subject: CHEBI:6709

subject_name: Meclizine


subject: CHEBI:135779

subject_name: Amrubicin

object_name: plasma cell myeloma


subject: CHEBI:15365

subject_name: Aspirin


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:167650

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:167650

object_name: B-cell neoplasm


subject: CHEBI:52172

subject_name: Nilotinib

object_name: melanoma


subject: CHEBI:52172

object_name: Acral Melanoma


subject: UMLS:C4045928

object_name: postherpetic neuralgia


subject: CHEBI:15773

subject_name: cyclohexylamine

object_name: Carcinoma breast stage IV


subject: CHEBI:75722

subject_name: Tramadol

object_name: Caesarean section


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: hepatitis A


subject: CHEBI:8228

object_name: hepatitis


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: HIV infection


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UMLS:C5205034

object_name: colorectal cancer


subject: UMLS:C5205034

object_name: colorectal carcinoma


subject: UMLS:C5205034

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:13890

subject_name: quavonlimab


subject: GTOPDB:13890


subject: GTOPDB:13890


subject: UNII:GG0AN49Y59

subject_name: QUAVONLIMAB


subject: UNII:GG0AN49Y59


subject: UNII:GG0AN49Y59


subject: UMLS:C4725918

subject_name: Quavonlimab


subject: UMLS:C4725918


subject: UMLS:C4725918


subject: CHEMBL.COMPOUND:CHEMBL4297785

subject_name: VIBOSTOLIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297785


subject: CHEMBL.COMPOUND:CHEMBL4297785


subject: UMLS:C5432276

subject_name: Vibostolimab


subject: UMLS:C5432276


subject: UMLS:C5432276


subject: UMLS:C4733023

object_name: Myelodysplasia


subject: UMLS:C4733023

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C4733023

object_name: childhood myelodysplastic syndrome


subject: UMLS:C4733023

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: UMLS:C4727210

object_name: Metastatic Esophageal Squamous Cell Carcinoma


subject: UMLS:C4727210

object_name: Unresectable Esophageal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: encephalitis


subject: MESH:C558471

subject_name: Hizentra


subject: UMLS:C5445109

subject_name: PCSK9 Inhibitors

object_name: aortic stenosis


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:606564

subject_name: prostaglandin E2(1-)

object_name: Premature rupture of membranes


subject: UMLS:C3813211

subject_name: Prostaglandin E2


subject: CHEBI:6413

subject_name: Letrozole

object_name: gestational trophoblastic neoplasm


subject: CHEBI:6413

object_name: hydatidiform mole, recurrent, 1


subject: UMLS:C2728259

subject_name: Program

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2728259

object_name: obesity


subject: UMLS:C2728259

object_name: Obesity, CTCAE


subject: CHEBI:39384

subject_name: Lufenuron


subject: CHEBI:39384


subject: CHEBI:39384


subject: UMLS:C5446554

object_name: Advanced Melanoma


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: hyperlipidemia


subject: CHEBI:30314

object_name: hyperlipoproteinemia


subject: CHEBI:30314

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:30314

object_name: Serum lipids high (finding)


subject: CHEBI:30314

object_name: Presenile dementia


subject: CHEBI:30314

object_name: dementia


subject: CHEBI:43796

subject_name: (S)-lipoic acid

object_name: Increased reactive oxygen species production


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796

object_name: Inflammation


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEMBL.COMPOUND:CHEMBL5095039

subject_name: GALLIUM GA 68 GOZETOTIDE

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C1568660

object_name: liver cancer


subject: UMLS:C1568660

object_name: liver neoplasm


subject: UMLS:C1568660

object_name: Adult Liver Carcinoma


subject: UMLS:C1568660

object_name: liver carcinoma


subject: UMLS:C1568660

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C1568660

object_name: Klatskin Tumor


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Myelodysplasia


subject: CHEBI:90841

subject_name: Cangrelor

object_name: ST-segment elevation myocardial infarction (STEMI)


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:3423

subject_name: Carmustine

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: chronic rhinosinusitis


subject: CHEBI:24261

subject_name: glucocorticoid


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Stage IVA Cervical Cancer AJCC v8


subject: GTOPDB:7988

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: GTOPDB:7988

object_name: Cervical carcinoma stage IVA


subject: GTOPDB:7988

object_name: Cervical Squamous Cell Carcinoma In Situ


subject: GTOPDB:7988

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: GTOPDB:7988

object_name: Cervical carcinoma stage IIB


subject: GTOPDB:7988

object_name: Stage IIB Cervical Cancer AJCC v8


subject: GTOPDB:7988

object_name: Cervical carcinoma stage IIA


subject: GTOPDB:7988

object_name: Stage IIA Cervical Cancer AJCC v6


subject: GTOPDB:7988

object_name: Stage IIA Cervical Cancer AJCC v8


subject: GTOPDB:7988

object_name: Stage IIA Cervical Cancer AJCC v7


subject: GTOPDB:7988

object_name: stage III cervical cancer


subject: GTOPDB:7988

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: GTOPDB:7988

object_name: Stage III Cervical Cancer AJCC v8


subject: GTOPDB:7988

object_name: Stage IB Cervical Cancer AJCC v8


subject: GTOPDB:7988

object_name: stage IB cervical cancer


subject: GTOPDB:7988

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: GTOPDB:7988

object_name: cervical adenosquamous carcinoma


subject: GTOPDB:7988

object_name: neoplasm


subject: UNII:6NS400BXKH

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:6NS400BXKH

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UNII:6NS400BXKH

object_name: Cervical carcinoma stage IVA


subject: UNII:6NS400BXKH

object_name: Cervical Squamous Cell Carcinoma In Situ


subject: UNII:6NS400BXKH

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: UNII:6NS400BXKH

object_name: Cervical carcinoma stage IIB


subject: UNII:6NS400BXKH

object_name: Stage IIB Cervical Cancer AJCC v8


subject: UNII:6NS400BXKH

object_name: Cervical carcinoma stage IIA


subject: UNII:6NS400BXKH

object_name: Stage IIA Cervical Cancer AJCC v6


subject: UNII:6NS400BXKH

object_name: Stage IIA Cervical Cancer AJCC v8


subject: UNII:6NS400BXKH

object_name: Stage IIA Cervical Cancer AJCC v7


subject: UNII:6NS400BXKH

object_name: stage III cervical cancer


subject: UNII:6NS400BXKH

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UNII:6NS400BXKH

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:6NS400BXKH

object_name: Stage IB Cervical Cancer AJCC v8


subject: UNII:6NS400BXKH

object_name: stage IB cervical cancer


subject: UNII:6NS400BXKH

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: UNII:6NS400BXKH

object_name: cervical adenosquamous carcinoma


subject: UNII:6NS400BXKH

object_name: neoplasm


subject: UMLS:C1570308

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C1570308

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C1570308

object_name: Cervical carcinoma stage IVA


subject: UMLS:C1570308

object_name: Cervical Squamous Cell Carcinoma In Situ


subject: UMLS:C1570308

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: UMLS:C1570308

object_name: Cervical carcinoma stage IIB


subject: UMLS:C1570308

object_name: Stage IIB Cervical Cancer AJCC v8


subject: UMLS:C1570308

object_name: Cervical carcinoma stage IIA


subject: UMLS:C1570308

object_name: Stage IIA Cervical Cancer AJCC v6


subject: UMLS:C1570308

object_name: Stage IIA Cervical Cancer AJCC v8


subject: UMLS:C1570308

object_name: Stage IIA Cervical Cancer AJCC v7


subject: UMLS:C1570308

object_name: stage III cervical cancer


subject: UMLS:C1570308

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UMLS:C1570308

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C1570308

object_name: Stage IB Cervical Cancer AJCC v8


subject: UMLS:C1570308

object_name: stage IB cervical cancer


subject: UMLS:C1570308

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: UMLS:C1570308

object_name: cervical adenosquamous carcinoma


subject: UMLS:C1570308

object_name: neoplasm


subject: PUBCHEM.COMPOUND:6728941

subject_name: cefditoren pivoxil

object_name: Rhinosinusitis


subject: CHEBI:59343

subject_name: Cefditoren


subject: UNII:N9B0H171MJ

subject_name: Derazantinib

object_name: combined hepatocellular carcinoma and cholangiocarcinoma


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Catheter related infection


subject: UMLS:C3854029

object_name: Catheter Related Infection, CTCAE


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:28001

subject_name: Vancomycin

object_name: adult hepatocellular carcinoma


subject: CHEBI:28001

object_name: liver cancer


subject: CHEBI:28001

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:28001

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:28001

object_name: metastatic colorectal cancer


subject: CHEBI:28001

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:71940

subject_name: Tadalafil

object_name: liver carcinoma


subject: CHEBI:71940


subject: CHEBI:71940


subject: CHEBI:71940


subject: CHEBI:71940


subject: CHEBI:71940


subject: CHEBI:71940


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Childhood Solid Neoplasm


subject: CHEBI:90001

object_name: Adult Solid Neoplasm


subject: CHEBI:90001

object_name: Solid Neoplasm


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0279328

object_name: myelofibrosis


subject: UMLS:C0279328

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UMLS:C0279328

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0279328

object_name: chronic myelomonocytic leukemia


subject: UMLS:C0279328

object_name: chronic monocytic leukemia


subject: UMLS:C0279328


subject: UMLS:C5848865

subject_name: Cell Therapy [APC]

object_name: Heart failure with normal ejection fraction


subject: CHEBI:91899

object_name: lung disorder


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:49159

subject_name: leukotriene antagonist


subject: UMLS:C3537183

subject_name: Leukotriene Receptor Antagonist [EPC]

object_name: asthma


subject: UMLS:C3537183


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:5470

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:5470

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:5470

object_name: amenorrhea


subject: PUBCHEM.COMPOUND:5470

object_name: Amenorrhea, CTCAE


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: endometriosis


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:6427


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: autoimmune encephalitis


subject: CHEBI:74327

subject_name: Ile-Val


subject: UMLS:C5959032

subject_name: Anti-ROR1/Anti-CD3/Anti-HSA Trispecific Antibody NM32-2668

object_name: gastric adenocarcinoma


subject: UMLS:C5959032

object_name: triple-negative breast carcinoma


subject: UMLS:C5959032

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5959032

object_name: lung adenocarcinoma


subject: UMLS:C5959032

object_name: fallopian tube carcinoma


subject: UMLS:C5959032

object_name: malignant mesothelioma


subject: UMLS:C5959032

object_name: endometrial cancer


subject: UMLS:C5959032

object_name: uterine corpus cancer


subject: UMLS:C5959032

object_name: endometrial carcinoma


subject: UMLS:C5959032

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5959032

object_name: clear cell renal carcinoma


subject: UMLS:C5959032

object_name: renal cell adenocarcinoma


subject: UMLS:C5959032

object_name: renal cell carcinoma


subject: UMLS:C5959032

object_name: Carcinoma of peritoneum


subject: UMLS:C5959032

object_name: peritoneal carcinoma


subject: UMLS:C5959032

object_name: melanoma


subject: UMLS:C5959032

object_name: melanoma, cutaneous malignant, susceptibility to, 1


subject: UMLS:C5959032

object_name: skin melanoma


subject: UMLS:C5959032

object_name: ovarian cancer


subject: UMLS:C5959032

object_name: ovarian carcinoma


subject: UMLS:C5959032

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5959032

object_name: leiomyosarcoma


subject: UMLS:C5959032

object_name: Childhood Leiomyosarcoma


subject: UMLS:C5959032

object_name: Adult Leiomyosarcoma


subject: UMLS:C5959032

object_name: adult liposarcoma


subject: UMLS:C5959032

object_name: liposarcoma


subject: UMLS:C5959032

object_name: pediatric liposarcoma


subject: UNII:17Y5QL6ENT

subject_name: DOCIPARSTAT

object_name: acute myeloid leukemia by FAB classification


subject: UNII:17Y5QL6ENT

object_name: acute myeloid leukemia


subject: UMLS:C0873137

subject_name: Korean ginseng preparation

object_name: Alzheimer disease


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: UMLS:C5444072

subject_name: Panax ginseng allergen


subject: PUBCHEM.COMPOUND:105162

object_name: obesity due to congenital leptin deficiency


subject: PUBCHEM.COMPOUND:105162

object_name: obesity due to leptin receptor gene deficiency


subject: PUBCHEM.COMPOUND:105162

object_name: morbid obesity


subject: UNII:G9FWZ369GX

subject_name: Fallypride


subject: UNII:G9FWZ369GX


subject: UNII:G9FWZ369GX


subject: UMLS:C5959827

subject_name: RAF Inhibitor DCC-3084

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5959827

object_name: RAS Family Gene Mutation


subject: UMLS:C5959827

object_name: RAF Family Gene Mutation


subject: UMLS:C5959827

object_name: non-small cell lung carcinoma


subject: UMLS:C5959827

object_name: BRAF gene mutation


subject: UMLS:C5959827

object_name: RAF1 Gene Mutation


subject: UMLS:C5959827

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5959827

object_name: melanoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Unstable angina (intermediate coronary syndrome)


subject: UMLS:C0700011

subject_name: Motilium

object_name: Gastroparesis due to diabetes mellitus


subject: CHEBI:31515

subject_name: Domperidone


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:54214995

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:54214995

object_name: hypertension


subject: PUBCHEM.COMPOUND:54214995

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: lung cancer


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: lung neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297777


subject: CHEMBL.COMPOUND:CHEMBL4297777

object_name: lung adenocarcinoma


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Bronchospasm, Exercise-Induced


subject: CHEBI:59773

object_name: exercise-induced bronchoconstriction


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: abdominal abscess


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: CHEBI:31781

subject_name: Lopinavir

object_name: hepatitis C


subject: UNII:DTW1NJ7IJH

subject_name: FASEDIENOL

object_name: social phobia


subject: UMLS:C4305823


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:3732

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:3732

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Plasma cell myeloma refractory


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Albuminuria


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Myelodysplasia


subject: CHEBI:91397

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:91397

object_name: childhood myelodysplastic syndrome


subject: CHEBI:91397

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:91397


subject: CHEBI:91397

object_name: Refractory High Risk Myelodysplastic Syndrome


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UMLS:C4087034

subject_name: Spleen Tyrosine Kinase Inhibitor HMPL-523

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:84036

subject_name: Aldoxorubicin

object_name: small cell lung carcinoma


subject: UMLS:C2348337


subject: CHEBI:139072

object_name: Chronic pelvic pain of female


subject: CHEBI:8614

subject_name: Psilocybin


subject: UMLS:C4053683

subject_name: ADC ADCT-301


subject: UMLS:C4053683

object_name: adult acute myeloid leukemia


subject: UMLS:C4053683

object_name: childhood acute myeloid leukemia


subject: UMLS:C4053683

object_name: acute myeloid leukemia


subject: CHEBI:135515

subject_name: Bendamustine

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C3892863

subject_name: filgrastim-sndz


subject: UNII:V5Y646AW8S

object_name: intracerebral hemorrhage


subject: UNII:V5Y646AW8S

object_name: Ischemic stroke


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Dental implant failed


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:65209

subject_name: Lucitanib

object_name: Solid Neoplasm


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: Thromboembolism


subject: CHEBI:31632

object_name: endometrial cancer


subject: CHEBI:31632

object_name: uterine corpus cancer


subject: CHEBI:31632

object_name: endometrial carcinoma


subject: CHEBI:31632

object_name: vulva cancer


subject: CHEBI:31632

object_name: vulva carcinoma


subject: CHEBI:31632

object_name: ovarian cancer


subject: CHEBI:31632

object_name: ovarian neoplasm


subject: CHEBI:31632

object_name: ovarian carcinoma


subject: CHEBI:31632

object_name: vaginal cancer


subject: CHEBI:31632

object_name: vaginal carcinoma


subject: CHEBI:31632

object_name: cervical cancer


subject: CHEBI:31632

object_name: cervical carcinoma


subject: CHEBI:31632

object_name: fallopian tube carcinoma


subject: CHEBI:31632

object_name: fallopian tube cancer


subject: CHEBI:31632

object_name: malignant soft tissue neoplasm


subject: CHEBI:31632

object_name: sarcoma


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED

object_name: Thromboembolism


subject: UMLS:C1145196

object_name: endometrial cancer


subject: UMLS:C1145196

object_name: uterine corpus cancer


subject: UMLS:C1145196

object_name: endometrial carcinoma


subject: UMLS:C1145196

object_name: vulva cancer


subject: UMLS:C1145196

object_name: vulva carcinoma


subject: UMLS:C1145196

object_name: ovarian cancer


subject: UMLS:C1145196

object_name: ovarian neoplasm


subject: UMLS:C1145196

object_name: ovarian carcinoma


subject: UMLS:C1145196

object_name: vaginal cancer


subject: UMLS:C1145196

object_name: vaginal carcinoma


subject: UMLS:C1145196

object_name: cervical cancer


subject: UMLS:C1145196

object_name: cervical carcinoma


subject: UMLS:C1145196

object_name: fallopian tube carcinoma


subject: UMLS:C1145196

object_name: fallopian tube cancer


subject: UMLS:C1145196

object_name: malignant soft tissue neoplasm


subject: UMLS:C1145196

object_name: sarcoma


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: anxiety disorder


subject: CHEBI:17045

object_name: Anxiety symptoms


subject: CHEBI:17045

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:17045

object_name: Anxiety, CTCAE 5.0


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: prostate disorder


subject: MESH:D056692

subject_name: Prebiotics

object_name: Impaired glucose tolerance in pregnancy


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:15414

subject_name: Adomet

object_name: bipolar I disorder


subject: CHEBI:15414

object_name: schizophrenia


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:67040


subject: UMLS:C5575602

subject_name: Cell Culture Serum

object_name: preeclampsia


subject: UMLS:C4045570

object_name: sensorineural hearing loss disorder


subject: UMLS:C4045570

object_name: X-linked mixed hearing loss with perilymphatic gusher


subject: UMLS:C4045570

object_name: noise induced hearing loss


subject: UMLS:C4045570

object_name: acoustic trauma (history)


subject: UMLS:C4045570

object_name: deafness


subject: UMLS:C4045570

object_name: hearing loss by exam


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: UMLS:C0119057

subject_name: GenHevac B Pasteur

object_name: HIV infection


subject: CHEBI:231342

subject_name: ceralasertib

object_name: Myelodysplasia


subject: CHEBI:231342

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:231342

object_name: childhood myelodysplastic syndrome


subject: CHEBI:231342

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:231342

object_name: leukemia


subject: CHEBI:231342

object_name: childhood leukemia


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: GTOPDB:1160

subject_name: hCG

object_name: Luteinized unruptured follicle syndrome


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: CHEBI:50815

subject_name: Norgestimate

object_name: Uses contraception (finding)


subject: CHEBI:27470

subject_name: Folic acid


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: ataxia telangiectasia


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:3757

object_name: Growth delay


subject: CHEBI:3757

object_name: Failure to Thrive


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate


subject: PUBCHEM.COMPOUND:3267


subject: PUBCHEM.COMPOUND:3267


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:68596

subject_name: alpha-Asp-Leu

object_name: Pancreas carcinoma resectable


subject: CHEBI:95165

object_name: thalassemia


subject: CHEBI:50131

subject_name: Decitabine


subject: UNII:REU6L9A46J

object_name: Refractory acute myeloid leukemia


subject: UNII:REU6L9A46J

object_name: Relapsing acute myeloid leukemia


subject: UNII:REU6L9A46J

object_name: myelodysplastic syndrome with excess blasts-2


subject: CHEBI:7459

subject_name: Naloxone

object_name: Congenital postural scoliosis


subject: CHEBI:7459

object_name: scoliosis


subject: CHEBI:7459

object_name: Scoliosis, CTCAE


subject: CHEBI:7459

object_name: post operative nausea and vomiting


subject: PUBCHEM.COMPOUND:25084151

subject_name: HISTRELIN ACETATE

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:25084151

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:25084151

object_name: prostate adenocarcinoma


subject: UMLS:C1618374

subject_name: INJECTION, HISTRELIN ACETATE, 10 MICROGRAMS ADMINISTERED


subject: UMLS:C1618374


subject: UMLS:C1618374


subject: CHEBI:5739

subject_name: histrelin


subject: CHEBI:5739


subject: CHEBI:5739


subject: UMLS:C0723551

subject_name: Supprelin


subject: UMLS:C0723551


subject: UMLS:C0723551


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: asthma


subject: CHEBI:32599

object_name: Episiotomy wound


subject: CHEBI:32599

object_name: Pain, Procedural


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Mechanical ventilation finding


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum

object_name: familial Dupuytren contracture


subject: UMLS:C0009053

object_name: palmar fibromatosis


subject: UMLS:C0009053

object_name: Dupuytren's contracture (physical finding)


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone

object_name: precocious puberty


subject: CHEBI:5520

subject_name: gonadorelin


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: CHEBI:77733

subject_name: Verapamil

object_name: type 1 diabetes mellitus 1


subject: CHEBI:77733

object_name: type 1 diabetes mellitus


subject: CHEBI:7553

subject_name: Niclosamide

object_name: colon carcinoma


subject: CHEBI:7553

object_name: colorectal cancer


subject: CHEBI:7553

object_name: colon cancer


subject: CHEBI:28364

subject_name: Icosapent

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:28364


subject: UNII:4685R51V7M

subject_name: Esmirtazapine

object_name: psychosis


subject: CHEBI:6950

subject_name: Mirtazapine


subject: UMLS:C4305831

object_name: Menorrhagia


subject: UMLS:C4305831

object_name: Menorrhagia, CTCAE


subject: UNII:G1G66XE93W

object_name: myeloproliferative neoplasm


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: UMLS:C5943246

object_name: atopic eczema


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: chronic graft versus host disease


subject: PR:000001379


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


subject: CHEBI:93772

subject_name: Ispinesib

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:93772

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:93772

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:93772

object_name: Stage III renal cell cancer


subject: CHEBI:93772

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:93772

object_name: Renal cell carcinoma recurrent


subject: CHEBI:93772

object_name: Renal cancer recurrent


subject: CHEBI:45267

subject_name: praziquantel

object_name: urinary schistosomiasis


subject: CHEBI:91583

subject_name: Praziquantel


subject: CHEBI:3082

subject_name: Betaxolol

object_name: open-angle glaucoma


subject: UMLS:C5417825

subject_name: AMG 506

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:62088

subject_name: Metamizole

object_name: anxiety


subject: CHEBI:62088

object_name: anxiety disorder


subject: CHEBI:62088

object_name: Anxiety symptoms


subject: CHEBI:62088

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:62088

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:62088

object_name: adverse effect


subject: CHEBI:62088

object_name: Adverse effects


subject: CHEBI:62088

object_name: Adverse reactions


subject: UMLS:C4687479

subject_name: Tidutamab

object_name: neuroendocrine neoplasm


subject: UMLS:C4687479

object_name: APUdoma


subject: UMLS:C4687479

object_name: digestive system neoplasm


subject: UMLS:C4687479

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:58561243

object_name: recurrent adult acute myeloid leukemia


subject: UNII:5HY8BYC3Q6

subject_name: ZELENIRSTAT


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Nutritional and Metabolic Diseases


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: malignant neoplasm of ovary stage IIIb


subject: CHEBI:45863

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:45863

object_name: malignant neoplasm of breast stage IIIb


subject: CHEBI:45863

object_name: malignant neoplasm of breast stage IIIc


subject: CHEBI:45863

object_name: Stage IV Gastric Cancer with Metastasis


subject: CHEBI:15365

subject_name: Aspirin

object_name: Vasospasm


subject: CHEBI:94721

subject_name: Triflusal


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: nervous system cancer


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: invasive breast carcinoma


subject: CHEBI:63605

object_name: bilateral breast carcinoma


subject: DRUGBANK:DB18696

object_name: respiratory distress syndrome in premature infants


subject: DRUGBANK:DB18696

object_name: newborn respiratory distress syndrome


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: schizophrenia


subject: UNII:T4H8FMA7IM

object_name: psychosis


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: multiple organ dysfunction syndrome


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: endometrial carcinoma


subject: UMLS:C4721816

object_name: cancer


subject: UMLS:C4721816

object_name: neoplasm


subject: UNII:7N03P021J8


subject: UNII:7N03P021J8


subject: UMLS:C2987343


subject: UMLS:C2987343


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Relapsed/refractory multiple myeloma


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Early Stage Breast Carcinoma


subject: UMLS:C1530450

subject_name: AMG 162


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: brain ischemia


subject: PUBCHEM.COMPOUND:22976653

object_name: cerebral infarction


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: CHEBI:18216

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: PUBCHEM.COMPOUND:20057296

subject_name: Ganglioside GM1 (18:1/16:0)


subject: PUBCHEM.COMPOUND:20057300


subject: CHEBI:177678

subject_name: Ganglioside GM1 (18:1/12:0)


subject: PUBCHEM.COMPOUND:20057297

subject_name: Sygen


subject: PUBCHEM.COMPOUND:20057299

subject_name: Ganglioside GM1 (18:1/22:0)


subject: PUBCHEM.COMPOUND:20057301


subject: CHEBI:177701

subject_name: Ganglioside GM1 (18:1/9Z-18:1)


subject: PUBCHEM.COMPOUND:20057303

subject_name: Ganglioside GM1 (d18:1/24:0)


subject: CHEBI:73110

subject_name: ganglioside GM1(1-)


subject: CHEBI:61048

subject_name: Ganglioside GM1


subject: PUBCHEM.COMPOUND:20057298

subject_name: Ganglioside GM1 (18:1/20:0)


subject: PUBCHEM.COMPOUND:22833613

subject_name: Ganglioside GM1 (d18:1/25:0)


subject: PUBCHEM.COMPOUND:20057302

subject_name: Ganglioside GM1 (d18:1/26:0)


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Lidocaine adverse reaction


subject: CHEMBL.COMPOUND:CHEMBL5315126

subject_name: FOLLITROPIN BETA

object_name: anovulation


subject: CHEMBL.COMPOUND:CHEMBL5315126

object_name: Female infertility associated with anovulation


subject: CHEBI:81569

subject_name: Follitropin


subject: CHEBI:81569


subject: UMLS:C0060787

subject_name: follitropin beta


subject: UMLS:C0060787


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Decreased total T cell count


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:125354

subject_name: Plerixafor


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Intrusive memories


subject: CHEBI:62466

subject_name: Prolycopene

object_name: transitional cell carcinoma


subject: CHEBI:15948

subject_name: Lycopene


subject: PUBCHEM.COMPOUND:122197547

subject_name: VOXILAPREVIR

object_name: chronic hepatitis C virus infection


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: familial Mediterranean fever


subject: UNII:37CQ2C7X93

object_name: autosomal recessive familial Mediterranean fever


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C0879250

subject_name: HER-2-neu peptide vaccine

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C0879250

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C0879250

object_name: Ovarian cancer stage IV


subject: UMLS:C0879250

object_name: HER2 positive


subject: UMLS:C0879250

object_name: HLA-A2 Positive Cells Present


subject: UMLS:C0069515

subject_name: erbB-2 Receptor


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UNII:FII75TFH5L

object_name: Childhood Glioblastoma


subject: UNII:FII75TFH5L

object_name: adult glioblastoma


subject: UMLS:C3273208


subject: UMLS:C3273208


subject: CHEBI:61397

subject_name: Neratinib

object_name: glioblastoma


subject: CHEBI:61397


subject: CHEBI:61397


subject: UMLS:C5706379

subject_name: Cytotoxic Agent-LAT1 Substrate QBS10072S


subject: UMLS:C5706379


subject: UMLS:C5706379


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: postmenopausal atrophic vaginitis


subject: CHEBI:4672

subject_name: Docetaxel

object_name: female breast carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Malignant neoplasm of female breast


subject: UNII:3A58010674


subject: CHEBI:42588

subject_name: Fenretinide

object_name: Neck Carcinoma


subject: CHEBI:42588

object_name: head and neck neoplasm


subject: CHEBI:42588

object_name: head and neck cancer


subject: UMLS:C0876217

subject_name: Vivelle-Dot

object_name: Menopause present (finding)


subject: UMLS:C0876217

object_name: Menopause


subject: CHEBI:77733

subject_name: Verapamil

object_name: impotence


subject: CHEBI:77733

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:77733

object_name: Erectile dysfunction


subject: CHEBI:57858

subject_name: atropinium

object_name: cardiac arrest


subject: CHEBI:57858

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: CHEBI:78887

subject_name: Tirapazamine

object_name: head and neck squamous cell carcinoma


subject: CHEBI:17026

subject_name: Progesterone

object_name: endogenous depression


subject: CHEBI:17026

object_name: major depressive disorder


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies

object_name: pancreatic neoplasm


subject: UMLS:C0003250

object_name: malignant pancreatic neoplasm


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5203232


subject: CHEBI:8499

subject_name: Propranolol

object_name: capillary infantile hemangioma


subject: CHEBI:8499

object_name: Spider nevus


subject: CHEBI:135630

subject_name: Drotaverine

object_name: Arrested active phase of labor


subject: CHEBI:135630

object_name: Labor Pain


subject: CHEBI:135630

object_name: Mild birth asphyxia, Apgar 4-7


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Heart Disease Risk Factors


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: cardiovascular surgery result: angina


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: renal pelvis/ureter urothelial carcinoma


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UMLS:C4329329


subject: CHEBI:50692

subject_name: Mifepristone

object_name: male breast carcinoma


subject: CHEBI:50692

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:50692

object_name: Carcinoma breast stage IV


subject: CHEBI:50692

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:50692

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:50692

object_name: Breast cancer recurrent


subject: CHEBI:50692

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:50692

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:50692

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:50692

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:50692

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:50692

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:50692

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:50692

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:50692

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:50692

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1310652

subject_name: Importal

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:93829

subject_name: Ifenprodil

object_name: interstitial lung disease 1


subject: CHEBI:93829

object_name: interstitial lung disease 2


subject: UMLS:C3273720

object_name: plasma cell myeloma


subject: MESH:C000728461

object_name: prostate adenocarcinoma


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Malignant pleural effusion


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:133021

subject_name: Venetoclax

object_name: hemophagocytic syndrome


subject: CHEBI:27834

subject_name: Pentostatin

object_name: Stomach cancer


subject: CHEBI:27834

object_name: gastric cancer


subject: CHEBI:94329

subject_name: Oxyphenonium


subject: CHEBI:94329


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: extramammary Paget disease


subject: UNII:DPT0O3T46P

object_name: sebaceous adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: skin appendage carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Angioimmunoblastic T-cell lymphoma stage III


subject: CHEBI:4026

object_name: Angioimmunoblastic T-cell lymphoma stage II


subject: CHEBI:4026

object_name: Intestinal T-cell lymphoma stage III


subject: CHEBI:4026

object_name: Angioimmunoblastic T-cell lymphoma stage IV


subject: CHEBI:4026

object_name: Intestinal T-cell lymphoma stage II


subject: CHEBI:4026

object_name: Intestinal T-cell lymphoma stage IV


subject: CHEBI:4026

object_name: ALK-negative anaplastic large cell lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791

object_name: ALK-positive anaplastic large cell lymphoma


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:8382

subject_name: Prednisone

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C5667096

subject_name: Oncolytic HSV-1 Expressing IL-12 and IL-15/IL-15-receptor Alpha VG2025

object_name: Childhood Solid Neoplasm


subject: UMLS:C5667096

object_name: Adult Solid Neoplasm


subject: UMLS:C5667096

object_name: Solid Neoplasm


subject: CHEBI:6121

subject_name: Ketamine

object_name: Other acute pain


subject: CHEBI:6121

object_name: Acute abdomen


subject: CHEBI:6121

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:6121

object_name: Back pain


subject: CHEBI:6121

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:6121

object_name: Flank Pain, CTCAE


subject: CHEBI:6121

object_name: Flank pain


subject: CHEBI:48947

subject_name: Clavulanic acid

object_name: cocaine dependence


subject: PUBCHEM.COMPOUND:2269

object_name: History of - respiratory disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:5134

object_name: bronchiectasis


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Colorectal cancer stage III


subject: PUBCHEM.COMPOUND:435949

object_name: Colorectal cancer stage II


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: UMLS:C1703313

subject_name: Papacarie

object_name: toothache


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: atopic eczema


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: CHEBI:601027

subject_name: Aliskiren

object_name: IgA nephropathy, susceptibility to, 1


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Malignant neoplasm of female genital organs


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: male infertility


subject: UNII:1C6V77QF41

object_name: inability to impregnate


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: MESH:D002136


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: PUBCHEM.COMPOUND:56842041

subject_name: Beacopp

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:56842041

object_name: lymphoma


subject: PUBCHEM.COMPOUND:56842041

object_name: pediatric lymphoma


subject: CHEBI:63631

subject_name: Topiramate

object_name: angle-closure glaucoma


subject: UNII:B93608MTGW

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C2726511

subject_name: Wilate

object_name: Hemorrhage


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Metastatic Breast Carcinoma


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570

object_name: invasive breast carcinoma


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Postoperative delirium


subject: CHEBI:8093

object_name: Emergence Delirium


subject: CHEBI:8093

object_name: Intraoperative Hemorrhage


subject: CHEBI:32278

subject_name: Urapidil

object_name: no feeling or sensation of skin


subject: CHEBI:32278

object_name: Sensory Loss


subject: CHEBI:32278

object_name: Surgical procedure finding


subject: CHEBI:32278

object_name: Blood Pressure Finding


subject: CHEBI:32278

object_name: Systemic arterial pressure


subject: CHEBI:32278


subject: CHEBI:32278


subject: CHEBI:32278


subject: CHEBI:67272

subject_name: Perifosine

object_name: Solid Neoplasm


subject: CHEBI:67272

object_name: Carcinoma breast stage IV


subject: CHEBI:67272

object_name: malignant soft tissue neoplasm


subject: CHEBI:67272

object_name: sarcoma


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: non-small cell lung carcinoma


subject: CHEBI:41774


subject: CHEBI:41774


subject: UNII:M17ILL71MC

subject_name: Efatutazone

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:M17ILL71MC

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Radiculopathy, Cervical


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C1723263

subject_name: poly(gamma-glutamic acid)

object_name: cervical intraepithelial neoplasia


subject: UMLS:C1723263

object_name: dysplasia of cervix


subject: CHEBI:15365

subject_name: Aspirin

object_name: chronic hypertension complicating pregnancy


subject: CHEBI:15365

object_name: placental abruption


subject: CHEBI:15365

object_name: Perinatal death


subject: UMLS:C5854654

subject_name: ATM Kinase Inhibitor WSD-0628

object_name: glioblastoma


subject: UMLS:C5854654

object_name: Childhood Glioblastoma


subject: UMLS:C5854654

object_name: adult glioblastoma


subject: UNII:7DR7JMB8BH


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: CHEBI:145592

object_name: Childhood Breast Carcinoma


subject: CHEBI:145592

object_name: breast carcinoma


subject: CHEBI:145592

object_name: breast cancer


subject: CHEBI:145592

object_name: Arthralgia


subject: CHEBI:145592

object_name: Joint Pain, CTCAE


subject: CHEBI:61025

subject_name: Chondroitin


subject: CHEBI:61025


subject: CHEBI:61025


subject: CHEBI:61025


subject: CHEBI:61025


subject: CHEBI:16137


subject: CHEBI:16137


subject: CHEBI:16137


subject: CHEBI:16137


subject: CHEBI:16137


subject: CHEBI:20993

subject_name: GLUCOSAMINE


subject: CHEBI:20993


subject: CHEBI:20993


subject: CHEBI:20993


subject: CHEBI:20993


subject: CHEBI:28393

subject_name: D-glucosamine


subject: CHEBI:28393


subject: CHEBI:28393


subject: CHEBI:28393


subject: CHEBI:28393


subject: CHEBI:35940

subject_name: Protirelin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:35940

object_name: obesity


subject: CHEBI:35940

object_name: Obesity, CTCAE


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: pancreatic neoplasm


subject: UNII:43K1W2T1M6

object_name: exocrine pancreatic carcinoma


subject: UNII:43K1W2T1M6

object_name: malignant pancreatic neoplasm


subject: CHEBI:59111

subject_name: URUSHIOL I

object_name: melanoma


subject: UMLS:C0309720

subject_name: PDC, veterinary product


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Hepatic impairment


subject: UMLS:C1709429


subject: UMLS:C5814308


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: malignant glioma


subject: UNII:PQX0D8J21J

object_name: Childhood Brain Neoplasm


subject: UNII:PQX0D8J21J

object_name: brain cancer


subject: UNII:PQX0D8J21J

object_name: brain neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C3827143

subject_name: Cetuximab-IRDye 800CW


subject: UMLS:C3827143


subject: UMLS:C3827143


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Prehypertension


subject: PUBCHEM.COMPOUND:9874151

subject_name: Angeliq


subject: UMLS:C1455162


subject: UMLS:C0592528

subject_name: Daunoxome

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4287789

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UMLS:C4287789

object_name: vitiligo


subject: CHEBI:64310

subject_name: Crizotinib

object_name: Recurrent Endometrial Cancer


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Metastatic osteosarcoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: cardiac arrest


subject: CHEBI:68558

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: burning mouth syndrome


subject: UMLS:C5960721

subject_name: Anti-LILRB4 Monoclonal Antibody BND-35

object_name: cancer


subject: UMLS:C5960721

object_name: neoplasm


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Hot Flashes, CTCAE


subject: CHEBI:7936

object_name: Hot flashes


subject: UNII:2AW48LAZ4I

subject_name: IMETELSTAT SODIUM

object_name: lung cancer


subject: UNII:2AW48LAZ4I

object_name: lung neoplasm


subject: UNII:2AW48LAZ4I

object_name: lung carcinoma


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UMLS:C4282299


subject: UMLS:C4282299


subject: UMLS:C4282299


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Urothelial carcinoma recurrent


subject: CHEBI:175901

object_name: bladder carcinoma in situ


subject: UMLS:C4287792

object_name: superficial urinary bladder carcinoma


subject: UMLS:C4287792

object_name: urinary bladder carcinoma


subject: UMLS:C4287792

object_name: urinary bladder cancer


subject: UMLS:C4287792

object_name: childhood bladder carcinoma


subject: UMLS:C4287792


subject: UMLS:C4287792


subject: UMLS:C4287792

object_name: Stage 0is Bladder Cancer AJCC v8


subject: UMLS:C4287792

object_name: transitional cell carcinoma


subject: CHEBI:50172

subject_name: acitretin

object_name: Chronic small plaque psoriasis


subject: CHEBI:50174


subject: CHEBI:8382

subject_name: Prednisone

object_name: Myasthenia Gravis, Ocular


subject: CHEBI:28241

subject_name: Papaverine

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEBI:28241

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:28241

object_name: Stage III Rectal Cancer AJCC v8


subject: UNII:M371870BYL

object_name: heart failure


subject: UNII:M371870BYL

object_name: Heart Failure, CTCAE


subject: UNII:M371870BYL

object_name: kidney failure


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: hypoactive sexual desire disorder


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:74705

subject_name: Met-Leu

object_name: mumps


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin